Effect of time restricted eating versus current practice in dietetics on glycaemic control and cardio-metabolic outcomes in individuals at risk of developing type 2 diabetes: Protocol for a multi-centre, parallel group, non-inferiority, randomised controlled trial

被引:0
|
作者
Charrouf, Rasha [1 ,2 ]
Parr, Evelyn B. [3 ]
Hutchison, Amy T. [1 ,2 ]
Flint, Steve A. [3 ,4 ]
Teong, Xiao Tong [1 ,2 ]
Wittert, Gary [1 ,2 ]
Vincent, Andrew D.
Brennan, Leah [5 ]
Devlin, Brooke L. [6 ]
Hawley, John A. [3 ]
Heilbronn, Leonie K. [1 ,2 ]
机构
[1] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5000, Australia
[2] South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Adelaide, SA 5000, Australia
[3] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Exercise & Nutr Res Program, Melbourne, Vic 3000, Australia
[4] Univ Melbourne, Dept Med, Diabet Technol Res Grp, Melbourne, Vic 3065, Australia
[5] La Trobe Univ, Sch Psychol & Publ Hlth, Wodonga, Vic 3689, Australia
[6] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld 4072, Australia
关键词
Time restricted eating (TRE); continuous; glucose monitoring; Current practice in dietetics; Obesity; Glycated haemoglobin (HbA1c); Psychological outcomes; QUALITY-OF-LIFE; INSTRUMENT; PREVENTION; AUSDRISK; HEALTH; IMPACT; MEN;
D O I
10.1016/j.cct.2024.107696
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Time restricted eating (TRE) is a dietary strategy that may improve metabolic health. However, no studies have compared TRE with current practice (CP) in dietetics. Hypothesis: TRE will not be inferior to CP to improve glycaemic control in individuals at risk of type 2 diabetes (T2D). Methods: This parallel group, randomised, non-inferiority, controlled trial randomised 247 participants by site and glycated haemoglobin (HbA1c) into TRE or CP (1:1) for 12 months. Participants were aged 35-70 years, with a body mass index (BMI) >25 but <45 kg/m(2), and score >= 15 on the Australian type 2 diabetes risk (AUSDRISK) assessment, without a diagnosis of T2D. Study visits were balanced between groups and all participants received five consultations at 0, 0.5, 1, 2 and 3 months. TRE followed a self-selected 9 h eating window (>= 0600 and <= 1900), whereas CP followed Australian dietary guidelines. Outcomes: The primary endpoint is the estimate of group mean difference (TRE vs CP) of HbA1c at 4 months in a covariate linear regression adjusting for stratification factors and sex. Secondary efficacy outcomes at 4 and 12 months are changes in fasting glucose, fasting insulin, HOMA-IR and nocturnal glucose by continuous glucose monitor incremental area under the curve and change in HbA1c at 12 months. Other endpoints are exploratory and will not be adjusted for multiplicity. Conclusions: We will determine whether TRE is an alternate strategy to current practice in dietetics to improve glucose control.
引用
收藏
页数:8
相关论文
共 14 条
  • [1] Effect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trial
    Baoyan Liu
    Yang Wang
    Jiani Wu
    Qian Mo
    Weiming Wang
    Liyun He
    Shiyan Yan
    Zhishun Liu
    BMC Complementary and Alternative Medicine, 14
  • [2] Effect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trial
    Liu, Baoyan
    Wang, Yang
    Wu, Jiani
    Mo, Qian
    Wang, Weiming
    He, Liyun
    Yan, Shiyan
    Liu, Zhishun
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [3] Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study
    Quist, Jonas S.
    Jensen, Marie M.
    Clemmensen, Kim K. B.
    Pedersen, Hanne
    Bjerre, Natasja
    Storling, Joachim
    Blond, Martin B.
    Albrechtsen, Nicolai J. Wewer
    Holst, Jens J.
    Torekov, Signe S.
    Vistisen, Dorte
    Jorgensen, Marit E.
    Panda, Satchidananda
    Brock, Christina
    Finlayson, Graham
    Faerch, Kristine
    BMJ OPEN, 2020, 10 (08):
  • [4] Comparing the effects of time-restricted eating on glycaemic control in people with type 2 diabetes with standard dietetic practice: A randomised controlled trial
    Parr, Evelyn B.
    Radford, Bridget E.
    Hall, Rebecca C.
    Steventon-Lorenzen, Nikolai
    Flint, Steve A.
    Siviour, Zoe
    Plessas, Connie
    Halson, Shona L.
    Brennan, Leah
    Kouw, Imre W. K.
    Johnston, Rich D.
    Devlin, Brooke L.
    Hawley, John A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 217
  • [5] Protocol for a 1-year randomised, controlled, parallel group, open-label trial on the effects and feasibility of time-restricted eating in individuals with type 2 diabetes- The Restricted Eating Time in the Treatment of Type 2 Diabetes (RESET2) trial
    Termannsen, Anne-Ditte
    Varming, Annemarie
    Bjerre, Natasja
    Wodschow, Helena Z.
    Hansen, Gitte S.
    Jensen, Nicole J.
    Persson, Frederik
    Bagger, Jonatan I.
    Panda, Satchidananda
    Finlayson, Graham
    Ewers, Bettina
    Hansen, Dorte L.
    Norgaard, Kirsten
    Rungby, Jorgen
    Grunnet, Louise G.
    Blond, Martin B.
    Hempler, Nana F.
    Faerch, Kristine
    Quist, Jonas S.
    DIABETIC MEDICINE, 2025,
  • [6] The clinical effectiveness and cost-effectiveness of a ‘stepping into day treatment’ approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial
    Madeleine Irish
    Bethan Dalton
    Laura Potts
    Catherine McCombie
    James Shearer
    Katie Au
    Nikola Kern
    Sam Clark-Stone
    Frances Connan
    A. Louise Johnston
    Stanimira Lazarova
    Shiona Macdonald
    Ciarán Newell
    Tayeem Pathan
    Jackie Wales
    Rebecca Cashmore
    Sandra Marshall
    Jon Arcelus
    Paul Robinson
    Hubertus Himmerich
    Vanessa C. Lawrence
    Janet Treasure
    Sarah Byford
    Sabine Landau
    Ulrike Schmidt
    Trials, 23
  • [7] The clinical effectiveness and cost-effectiveness of a 'stepping into day treatment' approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial
    Irish, Madeleine
    Dalton, Bethan
    Potts, Laura
    McCombie, Catherine
    Shearer, James
    Au, Katie
    Kern, Nikola
    Clark-Stone, Sam
    Connan, Frances
    Johnston, A. Louise
    Lazarova, Stanimira
    Macdonald, Shiona
    Newell, Ciaran
    Pathan, Tayeem
    Wales, Jackie
    Cashmore, Rebecca
    Marshall, Sandra
    Arcelus, Jon
    Robinson, Paul
    Himmerich, Hubertus
    Lawrence, Vanessa C.
    Treasure, Janet
    Byford, Sarah
    Landau, Sabine
    Schmidt, Ulrike
    TRIALS, 2022, 23 (01)
  • [8] A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study)
    Onuwe, Tolu
    Highton, Patrick J.
    Batchelor, David
    Brennan, Alan
    Caba, Molly
    Davies, Melanie J.
    Funnell, Mark P.
    Game, Frances
    Gillies, Clare L.
    Glab, Agnieszka
    Gray, Laura J.
    Gregg, Edward
    Hadjiconstantinou, Michelle
    Hall, Vicky
    Johnson, Vicki
    Petrie, John R.
    Pollard, Dan
    Rowntree, Hannah
    Tesfaye, Solomon
    Valabhji, Jonathan
    Webb, David
    Zaccardi, Francesco
    Khunti, Kamlesh
    DIABETIC MEDICINE, 2025,
  • [9] Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study)
    Hironaka, Junya
    Okada, Hiroshi
    Osaka, Takafumi
    Hashimoto, Yoshitaka
    Kobayashi, Genki
    Tanaka, Muhei
    Kogure, Akinori
    Mitsuhashi, Kazuteru
    Yoshimura, Takashi
    Kitagawa, Noriyuki
    Yano, Miho
    Kitamura, Akane
    Kishi, Akio
    Tsutsumi, Takeshi
    Yamazaki, Masahiro
    Ishii, Michiyo
    Mogami, Shinichi
    Nakamura, Naoto
    Fukuda, Takuya
    Tanaka, Toru
    Bamba, Ryo
    Sato, Eiko
    Hamaguchi, Masahide
    Fukui, Michiaki
    BMJ OPEN, 2025, 15 (03):
  • [10] Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose
    Pascale, Melanie
    Murray, Nikki
    Bachmann, Max
    Barton, Garry
    Clark, Allan
    Howe, Amanda
    Greaves, Colin
    Sampson, Mike
    BMC PUBLIC HEALTH, 2017, 17 : 1 - 21